Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Affamed Therapeutics, Antengene, Asieris Pharmaceuticals, Astrazeneca, Caliway Biopharmaceuticals, Iveric Bio, Recce Pharmaceuticals.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4SC, Ascendis, Clene, Escient, Lantern, Nervgen, Novartis, Nykode, Reviva, Zucara.